BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 16, 2025
See today's BioWorld
Home
» Other news to note for April 16, 2020
To read the full article
sign up for free
or
sign in
.
Other news to note for April 16, 2020
April 16, 2020
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acucela, Aeterna, Al Vivo, Atlas, Azurrx, Batavia, Biogen, Biohaven, Botanix, Cerespir, Cevec, Clinigen, Dynavax, Eagle, Elicio, Evotec, Evox, Fairjourney, F-star, Fusion Antibodies, Galapagos, Immutep, Iksuda, Inovio, Iontas, Jaguar, Kubota, Legochem, Leo, Leon-Nanodrugs, Medison, Napo, Novartis, Octapharma, PDS, Porton, Pulmatrix, Ryvu, SAB, Scitech, Sinovac, Soligenix, Starpharma, Synthon, Turning Point, Urogen, Valbiotis, Vivoryon.
BioWorld
Briefs
Other news to note
Coronavirus